Petar Bajic, MD
Urology · Cleveland, OHNPI 1053653501
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (33.6%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Boston Scientific at 34.9% of the total. Among urology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 577 payments — averaging $258.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$52K
- Coloplast$42K
- Endo Pharmaceuticals Inc.$25K
- Olympus America Inc.$16K
- Endo USA, Inc.$8K
- Marius Pharmaceuticals, Inc$3K
- plus $3K from 18 others
Across 9 payments — averaging $33,506 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Coloplast$279K
- Endo USA, Inc.$22K
What the payments were for
- Consulting fees$50,16834%
- Speaking & faculty fees$15,82011%
- Grants$40,64927%
- Travel & lodging$21,98315%
- Food & beverage$20,53314%
- Education$850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 187 | $52,039 |
| Coloplast | 227 | $42,079 |
| Endo Pharmaceuticals Inc. | 46 | $25,252 |
| Olympus America Inc. | 37 | $16,105 |
| Endo USA, Inc. | 14 | $7,777 |
| Marius Pharmaceuticals, Inc | 1 | $3,000 |
| Procept Biorobotics Corporation | 31 | $1,222 |
| Antares Pharma, Inc. | 8 | $284 |
| Dendreon Pharmaceuticals LLC | 3 | $226 |
| Tolmar, Inc. | 6 | $171 |
| Travere Therapeutics, Inc. | 1 | $140 |
| Carl Zeiss Meditec USA, Inc. | 1 | $125 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $124 |
| Teleflex LLC | 1 | $120 |
| Innovation Technologies Inc | 1 | $115 |
| Valencia Technologies Corporation | 1 | $109 |
| Baxter Healthcare | 1 | $89 |
| EDAP Technomed Inc | 1 | $71 |
| Convatec Inc. | 3 | $69 |
| Medtronic | 2 | $40 |
| Johnson & Johnson | 1 | $25 |
| Olympus Corporation Of The Americas | 1 | $22 |
| Neotract Inc. | 1 | $19 |
| 180 Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL ERECTILE DYSFUNCTION$41,117
- TITAN$35,718
- XIAFLEX$31,675
- iTIND System$15,923
- Luja Coude$2,186
- AMS$1,382
- AMS 700$1,331
- AMS 700 CXR RTE KIT$1,173
- rezum Generator$901
- GENERAL - THERAPIES$704
- GENERAL BPH$540
- ALTIS$523
- AQUABEAM SYSTEM$292
- LithoVue$250
- AquaBeam Robotic System$237
- PENILE & TESTICULAR RECONSTRUCTN$160
- (815) Thiola$140
- CLINICAL T$134
- XYOSTED$130
- Bard Urinary Drainage Bag$124
How this compares
$149,237 in reported general payments places this provider in the 95th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 51 | $27,948 |
| Mirabegron ErMirabegron | 20 | $11,101 |
| Testosterone Cypionate | 73 | $2,908 |
| Tamsulosin Hcl | 173 | $2,554 |
| Trospium Chloride | 41 | $2,388 |
| Solifenacin Succinate | 22 | $2,352 |
| Testosterone | 16 | $2,093 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 43 | $857 |
| Finasteride | 40 | $647 |
| Celecoxib | 12 | $285 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 47 | $197 |
| Oxybutynin Chloride ErOxybutynin Chloride | 11 | $127 |
| Levofloxacin | 20 | $111 |
| Cephalexin | 14 | $67 |
Paid to pharmacies, not to this prescriber.
Other urology in Cleveland
- Howard GoldmanCleveland$721K
- Sriharan SivalingamCleveland$276K
- Sandip VasavadaCleveland$263K
- Jihad KaoukCleveland$234K
- Ruben OlivaresCleveland$184K
- Raymond RackleyCleveland$152K
- Jorge Gutierrez AcevesCleveland$90K
- Kenneth AngermeierCleveland$69K
- Roger KhouriCleveland$57K
- Xinyuan ZhangCleveland$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.